Posted on 28 August 2010 by admin
Headlines: "AMFIL Technologies Reports Food-Borne Illnesses Costing U.S. Economy an
Estimated $152 Billion "
AMFIL Technologies, Inc., integrator of
ozone-based cleaning and antimicrobial systems for the food and beverage
industry, is pleased to report inquiries for their non-chemical based mPact
ozone systems continue to increase worldwide. This increase is a result of the
rise in salmonella outbreaks and other food-borne illnesses.
Read:
AMFE
NEWS
In a March 3, 2010 article in Bloomberg Business Week, it was reported
food-borne illnesses are costing the U.S. economy an estimated $152 billion in
health related expenses.
AMFE's mPact system has the technology to combat these issues!
AMFIL
Technologies, Inc. has already begun responding to multiple inquiries. Following
final testing in Canada, the system will be relocated to the U.S. in order to
meet the rising demand of the technology.
Did you know that food production is the fastest growing sector in the
world?
CNN
Magazine
OTCReporter.com, HotOTCChina.com, OTCPennystockreporter.com,
OTCPennypicks.com, and Chartpenny.com (the “Websites”) are owned by Oceanic
Consulting, LLC ("Oceanic") and Garden State Resources NJ, LLC ("Garden State")
(Oceanic and Garden State are collectively referred to herein as the "LLC
Companies) , both of which are New Jersey limited liability
corporations (the Websites and its owners, the LLC Companies, and their
affiliates, directors and officers and its immediate family members are referred
to in our Disclaimer as "OTCR" or "we" or "us" or "our"). Because we receive
monetary or securities compensation, most often in the form of
common stock (hereafter referred to as the "Shares") for our dissemination of
publicly disseminated information (the “Information”) regarding various issuers
of securities, we disclose our specific compensation herein and in our
individual reports of profiled issuers. The LLC Companies received
fifteen thousand dollars and two million free trading shares from a
non-affiliate third party shareholder of AMFE Amfil Technologies Inc. in return
for OTCR’s services to publicly and electronically disseminate information
pertaining to Amfil Technologies Inc. We will regularly and routinely sell the
remaining two million shares that we hold before, during and after our
dissemination of the Information, most frequently during the dissemination of
the Information. It is imperative that all readers of the above
compensations disclosure carefully review our Disclaimer in its entirety, which
contains important information about penny stocks, our operations, the limited
nature of the Information and various risks attendant to the companies that we
profile, including that: (a) we receive our compensation in free trading shares,
which we will sell immediately upon their receipt as well as during the
dissemination of such Information or within hours, days, weeks or months
thereafter, or at any time; as a result, our selling activities will cause
significant volatility in the Issuer’s stock price and/or significantly depress
the Issuer’s stock price; (b) we will buy and sell the Shares in the open market
before, during or after the dissemination of the Information or at any time,
which will cause significant volatility in the Issuer’s stock price and/or
significantly depress or increase the Issuer’s stock price; (c) there is an
inherent and actual conflict of interest that exists between our Readers’
interests and our interests because we: (i) receive the Shares as compensation
for disseminating the Information and thereafter sell those Shares at any time
for monetary gain, including at the same time the Information is being
disseminated or shortly thereafter or at any time; and (ii) buy and sells the
Profiled Company’s shares in the open market at the same time or before the
Information is being disseminated or shortly after the dissemination of the
Information or at any time. Our gains from sale of the Shares may be
substantial.
| This message was sent from OTCReporter to Subscriber. It was sent from: OTCReporter.com, P.O. Box 273, Rumson, NJ 07760. You can modify/update your subscription via the link below. |
Email Marketing by
 |
|